• Collaboration to advance Global Drug Discovery Infrastructure
    Matthew Segall

News & Views

Collaboration to advance Global Drug Discovery Infrastructure

Nov 26 2020

Drug discovery software developer Optibrium has announced a collaboration with US-based MSD which has adopted the Cambridge, UK company's StarDrop™ software as a central component of their cheminformatics infrastructure. The partnership will also include the joint development of new tools, to improve cycle times, efficiency and productivity of the drug discovery process.

Dr Matthew Segall, Optibrium’s CEO, commented, “We are delighted to enter this collaboration to contribute to MSD’s world-leading cheminformatics infrastructure. We look forward to working together to advance new tools based around StarDrop to further refine our compound design platform.”

MSD is a tradename of Merck & Co Inc, Kenilworth NJ

Further information www.online

Digital Edition

Lab Asia 29.6 Dec

December 2022

In This Edition Chromatography - Optimising Viral Vector Purification Strategies with Multimodal Chromatography - Key UHPLC Characteristics Required for High throughput LC-MS - New Low Volu...

View all digital editions


Nano Tech 2023

Feb 01 2023 Tokyo, Japan

Medlab Middle East

Feb 06 2023 Dubai, UAE


Feb 14 2023 Cologne, Germany

SLAS 2023

Feb 25 2023 San Diego, CA, USA

View all events